Category: Zacks Small Cap Research
By John Vandermosten, CFANASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT Initiating Coverage We are initiating coverage of Lantern Pharma Inc., (NASDAQ:LTRN) with a current valuation of $28 per share. Lantern is a new type of drug development company ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of Nur ...
By Beth Senko, CFAOTC:UCASU READ THE FULL UCASU RESEARCH REPORT The pandemic continues to throw uncertainty into the economy and markets, making it difficult, if not impossible, for many to look past 2020, or even next week. Recent studies suggest th ...
By John Vandermosten, CFANASDAQ:NOVN Novan, Inc. (NASDAQ:NOVN) announced today that in vitro investigation of NITRICIL’s (berdazimer sodium) antiviral effect against SARS-CoV-2 infected 3D tissue model produced favorable results, demonstrating the po ...
By M. MarinNASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD) is a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threaten ...
NASDAQ:ANPC Biophysical Properties of Blood and Cancer Overview AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) adopts a novel approach to screening and detecting cancer that we see as establishing a new paradigm in routine checkup screening, as we ...
By John Vandermosten, CFANASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT Initiating Coverage We are initiating coverage of electroCore, Inc. (NASDAQ:ECOR), a commercial stage device company, with a valuation of $4.00 per share. This target price is ba ...
By John Vandermosten, CFANASDAQ:KTRA READ THE FULL KTRA RESEARCH REPORT Since Our Initiation Since our initiation on September 9th, Kintara Therapeutics Inc. (NASDAQ:KTRA) has reported 2020 financial and operational results in a press release and in ...
NYSE:TRC Zacks Small-Cap Research has initiated research coverage on Tejon Ranch Company (NYSE:TRC), a real estate-development company that targets maximizing shareholder value through monetization of its land-based assets; TRC’s principal asset is i ...
By David Bautz, PhDNASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Collaboration with Takeda for ARO-AAT On October 8, 2020, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced a collaboration with Takeda Pharmaceutical Company Ltd ...